Hisamitsu Pharmaceutical Completes $428 Million Noven Pharmaceuticals Inc. Purchase

AP -- Hisamitsu Pharmaceutical Co. completed its $428 million purchase of Florida-based Noven Pharmaceutical Inc., the companies said Friday.

MORE ON THIS TOPIC